Brind.

The company Tempus is seeking FDA clearance for its technology and listed on the NASDAQ stock exchange.

2 reports, 2 independent Updated Sep 1

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

The company Tempus is seeking FDA clearance for its technology and listed on the NASDAQ stock exchange.

Who's involved

What this event is mainly about

Tempus FDA Nasdaq

Keep exploring

The entities involved

Tempus
biotechnology company based in Chicago, Illinois

Nothing else this week.
FDA
- Sanofi, Regeneron, and Bayer are involved in new market developments, including FDA submissions regarding eczema and eye care treatments.17:04
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.14:49
Nasdaq
American fully electronic stock exchange
- Apple Inc. is noted as a major holding in the Nasdaq-100 Index, alongside discussions of QQQ and QQQE strategies.17:24
- Capital Group and Nasdaq are mentioned in the context of ETFs being used to build a portfolio.17:07

Coverage

Newest first; wire copies grouped

Sep 1insidermonkey.com
Jun 23yahoo.com